{"id":61537,"date":"2025-07-08T12:01:09","date_gmt":"2025-07-08T10:01:09","guid":{"rendered":"https:\/\/www.aiom.it\/?p=61537"},"modified":"2025-07-11T12:06:03","modified_gmt":"2025-07-11T10:06:03","slug":"avelumab-plus-sacituzumab-govitecan-versus-avelumab-monotherapy-as-first-line-maintenance-treatment-in-patients-with-advanced-urothelial-carcinoma-javelin-bladder-medley-interim-analysis","status":"publish","type":"post","link":"https:\/\/www.aiom.it\/en\/avelumab-plus-sacituzumab-govitecan-versus-avelumab-monotherapy-as-first-line-maintenance-treatment-in-patients-with-advanced-urothelial-carcinoma-javelin-bladder-medley-interim-analysis\/","title":{"rendered":"Avelumab plus sacituzumab govitecan versus avelumab monotherapy as first-line maintenance treatment in patients with advanced urothelial carcinoma: JAVELIN Bladder Medley interim analysis"},"content":{"rendered":"<p>&nbsp;<\/p>\n<p><em>J Hoffman-Censits, M Tsiatas, P M-H Chang, M Kim, L Antonuzzo, S J Shin, G Gakis, N Blais, S H Kim, A Smith, J A Arranz Arija, Y L Su, F Zagouri, M Maruzzo, C Tournigand, F Forget, A Schneider, K Tyroller, N Jacob, P Grivas, B P Valderrama<img loading=\"lazy\" decoding=\"async\" class=\"alignright size-medium wp-image-61529\" src=\"https:\/\/www.aiom.it\/wp-content\/uploads\/2025\/07\/AnnalsOfOncology_May2025-232x300.jpg\" alt=\"\" width=\"232\" height=\"300\" srcset=\"https:\/\/www.aiom.it\/wp-content\/uploads\/2025\/07\/AnnalsOfOncology_May2025-232x300.jpg 232w, https:\/\/www.aiom.it\/wp-content\/uploads\/2025\/07\/AnnalsOfOncology_May2025.jpg 595w\" sizes=\"auto, (max-width: 232px) 100vw, 232px\" \/><\/em><\/p>\n<p><em>Annals of Oncology<\/em>, 2025 May 30<\/p>\n<p style=\"text-align: right;\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40456670\/\">Abstract link<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>Copyright \u00a9 2025 The Author(s). Published by Elsevier Ltd.. All rights reserved.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; J Hoffman-Censits, M Tsiatas, P M-H Chang, M Kim, L Antonuzzo, S J Shin, G Gakis, N Blais, S H Kim, A Smith, J A Arranz Arija, Y L Su, F Zagouri, M Maruzzo, C Tournigand, F Forget, A Schneider, K Tyroller, N Jacob, P Grivas, B P Valderrama Annals of Oncology, 2025 May [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":61533,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[255],"tags":[],"class_list":["post-61537","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articoli-scientifici-en"],"_links":{"self":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/61537","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/comments?post=61537"}],"version-history":[{"count":1,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/61537\/revisions"}],"predecessor-version":[{"id":61538,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/61537\/revisions\/61538"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/media\/61533"}],"wp:attachment":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/media?parent=61537"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/categories?post=61537"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/tags?post=61537"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}